One of the most common causes of neurological disabilities are malformations of cortical development (MCD). A useful animal model of MCD consists of prenatal exposure to methylazoxymethanol (MAM), resulting in a postnatal phenotype characterized by cytological aberrations reminiscent of human MCD. Although postnatal effects of MAM are likely a consequence of prenatal events, little is known on how the developing brain reacts to MAM. General assumption is the effects of prenatally administered MAM are short lived (24 h) and neuroblast-specific. MAM persisted for several days after exposure in utero in both maternal serum and fetal brain, but at levels lower than predicted by a neurotoxic action. MAM levels and time course were consistent with a different mechanism of indirect neuronal toxicity. The most prominent acute effects of MAM were cortical swelling associated with mild cortical disorganization and neurodegeneration occurring in absence of massive neuronal cell death. Delayed or aborted vasculogenesis was demonstrated by MAM's ability to hinder vessel formation. In vitro, MAM reduced synthesis and release of VEGF by endothelial cells. Decreased expression of VEGF, AQP1, and lectin-B was consistent with a vascular target in prenatal brain. The effects of MAM on cerebral blood vessels persisted postnatally, as indicated by capillary hypodensity in heterotopic areas of adult rat brain. In conclusion, these results show that MAM does not act only as a neurotoxin per se, but may additionally cause a short-lived toxic effect secondary to cerebrovascular dysfunction, possibly due to a direct anti-angiogenic effect of MAM itself.
One of the most common causes of neurological disabilities are malformations of cortical development (MCD) . A useful animal model of MCD consists of prenatal exposure to methylazoxymethanol (MAM), resulting in a postnatal phenotype characterized by cytological aberrations reminiscent of human MCD. Although postnatal effects of MAM are likely a consequence of prenatal events, little is known on how the developing brain reacts to MAM. General assumption is the effects of prenatally administered MAM are short lived (24 h) and neuroblast-specific. MAM persisted for several days after exposure in utero in both maternal serum and fetal brain, but at levels lower than predicted by a neurotoxic action. MAM levels and time course were consistent with a different mechanism of indirect neuronal toxicity. The most prominent acute effects of MAM were cortical swelling associated with mild cortical disorganization and neurodegeneration occurring in absence of massive neuronal cell death. Delayed or aborted vasculogenesis was demonstrated by MAM's ability to hinder vessel formation. In vitro, MAM reduced synthesis and release of VEGF by endothelial cells. Decreased expression of VEGF, AQP1, and lectin-B was consistent with a vascular target in prenatal brain. The effects of MAM on cerebral blood vessels persisted postnatally, as indicated by capillary hypodensity in heterotopic areas of adult rat brain. In conclusion, these results show that MAM does not act only as a neurotoxin per se, but may additionally cause a short-lived toxic effect secondary to cerebrovascular dysfunction, possibly due to a direct anti-angiogenic effect of MAM itself. (Ferriero and Dempsey, 1999; Scher, 2003) . Common models of MCD consist of prenatal exposure to antiproliferative agents, such as methylazoxymethanol (MAM), and methyl mercury. The proposed mechanism of action leading to MCD is based on toxicity towards differentiating neurons. The corresponding postnatal phenotype will thus be determined by the exact stage of development at which exposure occurs (Bassanini and Battaglia, 2006; Battaglia and Bassanini, 2006a,b; Battaglia et al., 2003a,b) .
Methylazoxymethanol is a potent genotoxin, and the aglycone of Cycasin (Balduini et al., 1989; Calcagnotto et al., 2002; Cattabeni and Di Luca, 1997) . It is found in the seeds and roots of the Cycad plant (Eizirik and Kisby, 1995; Esclaire et al., 1999) . MAM has been used to produce developmental structural abnormalities in the rodent brain (Cattabeni and Di Luca, 1997; Jones and Gardner, 1976) . After administration, MAM is converted to methyl-diazonium which is responsible for the methylation of DNA in the O6 and N7 positions of guanine bases (Matsumoto et al., 1972; Nagata and Matsumoto, 1969) .
MAM has been proposed to selectively target neuroepithelial cells with an antiproliferative action on dividing, but not quiescent cells (Cattaneo et al., 1995) . The antiproliferative effect of this compound has been suggested to occur in a rather narrow time window with a maximal activity at 12 h after administration (Matsumoto et al., 1972) . A double dose of MAM administered on gestational day 15 results in a disruption of neuronal cortical layering in the offspring. This is associated with MCD comparable to human periventricular nodular heterotopias (Colacitti et al., 1998; Sancini et al., 1998) .
Another example of brain damage after exposure to agents with antimitotic properties is methylmercury fetal poisoning (Battaglia and Bassanini, 2006a,b; Ferriero and Dempsey, 1999 
